Work

Huawei Cloud and Liaoning Pharmaceutical Foreign Trade Corporation join hands to promote the digital transformation of enterprises.

Under the background of the development of digital economy in the “14th five-year Plan”, WITMED has become a major trend in the development of the industry. with the deep integration of artificial intelligence, cloud computing and other new technologies and industries, digital health is also continuing to innovate and develop. Huawei Clould assist Liaoning Pharmaceutical Foreign Trade Corporation. (hereinafter referred to as: Liaoning Pharm) to accelerate the process of digital transformation and work together to create an intelligent pharmaceutical integrated service platform.

Comply with the trend, actively explore and build a solid base for cloud development

As a leading pharmaceutical company in Liaoning province, Liaoning Pharm has always been committed to becoming a provider of patient-centered integrated service solutions. In drug distribution, device distribution, international trade, three-party logistics, terminal retail, emerging business and other areas to provide quality products and services.

In January 2015, with the change and breakthrough of information technology, the company specially set up a information center to solve business problems through software development, straighten out business processes, and developed multiple business systems for the company, and gradually had a relatively complete IT framework to meet the company’s information technology needs. 

However, in the face of the continuous growth of enterprise business, new difficulties and challenges also emerge as the times require. Coupled system, decentralized data structure, uninterrupted operation, no case reference. In the face of many challenges, Liaoning Pharm successfully shook hands with Huawei Cloud, taking “full-business system on the cloud” as an important foothold to implement the group’s “digital health” development strategy, with no user perception and uninterrupted business.

If you want to do good work, you must first sharpen your tools and continue to grow in practice.

In fact, the cooperation between the two sides is not only to use the cloud, but also to make good use of the cloud to carry out deeper technical exchanges. However, it is subject to the influence of region and epidemic, and there is no unified cooperation platform. Even if technical cooperation is carried out remotely, it is difficult to integrate, difficult to standardize, difficult to operate and maintain, and difficult to coordinate.

In order to open up the situation, the Information Center decided to upgrade the technology platform from local to Huawei Cloud DevCloud cloud development platform, which integrates Huawei’s R & D practices, cutting-edge R & D concepts and advanced R & D tools to achieve ready-to-use, anytime and anywhere delivery of software in the cloud to implement full lifecycle management.

From the individual to the whole, digitization is not simply replacing labor with machines.

Enterprise digital transformation is not a simple machine replacement of labor, but the digitalized redefinition and empowerment of business activities, processes, services, staff capabilities and other aspects. Through the establishment of a system platform for achieving employee value, we can open up the whole chain of business data, guide employees to form packable business capabilities, and deal with uncertain future development with the flexibility of removable reconstruction. Let every employee participate in the development of artificial intelligence and enterprise digital transformation and development, build borderless digital productivity, and promote the continuous update iteration of “quality service”.

Based on the digital base provided by Huawei Cloud, Liaoning Pharm will continue to aim at digital development and create a multi-plate rotating service system with science and technology, so as to meet the needs of more customers and benefit more people. In the future, the two sides will continue to cooperate in big data, AI and other areas to enrich the intelligent pharmaceutical integrated service platform, digitally driven innovation and promote the rapid development of enterprise digitalization.

发表评论

邮箱地址不会被公开。 必填项已用*标注